Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is a cross-sectional study. The purpose is to understand the characteristics of Chinese medicine constitutional syndrome in patients with polycystic ovary. In addition, the health-related quality of life (SF-36), mental state (stress, depression) of patients with polycystic ovary , Anxiety) and the relationship between hormone biochemical indicators and TCM constitutional syndromes, to develop a pioneering study on TCM constitution diagnosis and life guidelines for polycystic ovarian patients and future clinical adjuvant therapy.
The study conducted in the Obstetrics and Gynecology Department of the Neihu District of the Taipei Three Military General Hospital. It is expected that 200 cases of polycystic ovary will be diagnosed by specialists; "Quality of Life Questionnaire (SF-36)" evaluates the quality of life of patients; "BAI and BDI-II" evaluates patients 'anxiety and depression; "Stress Perception Scale" evaluates patients' life stress And testing the blood indexes of patients such as FSH, LH, E2, testosterone, TSH, prolactine. Observe the correlation between the quality of life, psychological state, and blood test values of polycystic ovarian patients with physical characteristics of traditional Chinese medicine.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Polycystic Ovary Syndrome | Polycystic Ovary Syndrome women |
| |
| control | non- Polycystic Ovary Syndrome women |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| no intervention | Other | no intervention |
|
| Measure | Description | Time Frame |
|---|---|---|
| participants with PCOS and non-PCOS assessed Chinese Body Constitution & Syndromes by Body Constitution Questionnaire | The TCM Body Constitution Questionnaire (BCQ) was developed by Su and is a tool used to measure and study constitution deviations clinically. The questionnaire comprises 44 questions and employs a Likert 5-point scale (from 1, "Never happens," to 5, "Always happens"). The instrument consists of three subscales. The yang-xu and yin-xu constitution subscales each have 19 questions, and the stasis constitution subscale has 16 questions. The three measures share some questions. The higher the score is, the more significant the constitution deviation is. When the yang-xu constitution score is ≥ 30.5, the respondent is diagnosed as yang-xu. When the yin-xu constitution score is ≥ 29.5, the respondent is diagnosed as yin-xu. For the phlegm stasis constitution, the standard is ≥ 26.5 points. The instrument has favorable factorial validity. Cronbach's α of each subscale is 0.85-0.88, and Cronbach's αof the overall BCQ reaches 0.90. | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| Measure | Description | Time Frame |
|---|---|---|
| work schedule (Day shift, Evening shift, Night shift, Not fixed, or Unemployed) of participants with PCOS and non-PCOS were collected | Participant reply her work schedule (Day shift, Evening shift, Night shift, Not fixed, or Unemployed) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
Not provided
Inclusion Criteria:
A polycystic ovarian patient was diagnosed by a specialist in obstetrics and gynecology according to the diagnostic criteria set by the Rotterdam ESHRE / ASRM-sponsored PCOS workshop group (2004) in 2003.
Exclusion Criteria:
Not provided
Not provided
Not provided
Women diagnosed with Polycystic Ovary Syndrome and non Polycystic Ovary Syndrome
Not provided
| ID | Term |
|---|---|
| D011085 | Polycystic Ovary Syndrome |
| D013577 | Syndrome |
| ID | Term |
|---|---|
| D010048 | Ovarian Cysts |
| D003560 | Cysts |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 |
Not provided
Not provided
Not provided
Not provided
Not provided
| average sleep duration of participants with PCOS and non-PCOS were collected |
Participant reply her average sleep duration (hours) |
| No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| habit of staying up late of participants with PCOS and non-PCOS were collected | Participant reply her frequency(No, Sometimes, Often) of staying up late (sleeping after midnight) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| habit of smoking of participants with PCOS and non-PCOS were collected | Participant reply her frequency of smoking (No, Sometimes, Less than a pack a day) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| habit of drinking of participants with PCOS and non-PCOS were collected | Participant reply her frequency of drinking (No, Sometimes, often) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| habit of exercise of participants with PCOS and non-PCOS were collected | Participant reply her frequency of exercise (No, Sometimes, often) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| dietary habit (Nonvegetarian or vegetarian) of participants with PCOS and non-PCOS were collected | Participant reply her dietary habit (Nonvegetarian or vegetarian) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| dietary flavor preference (sour, bitter,sweet, spicy, salty) of participants with PCOS and non-PCOS were collected | Participant reply yes or no about her dietary flavor preference (sour, bitter,sweet, spicy, salty) | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| Anxiety of participants with PCOS and non-PCOS as assessed by Beck Anxiety Inventory | The Beck Anxiety Inventory (BAI) was established by Aaron T. Beck and his research team to measure the anxiety levels of adults and teenagers. It is a self-completed questionnaire with 21 items. The questions ask respondents whether they have experienced some common symptoms of anxiety in the previous week, including numbness or tingling, feeling hot, being unable to relax, and fear of the worst happening. The respondents report on a 4-point Likert scale that ranges from 0 (Not at all) to 3 (Severely - it bothered me a lot). The higher the total score is, the more severe the anxiety symptoms are. A total score of 0-7 implies the mildest anxiety, 8-15 is mild anxiety, 16-25 represents moderate anxiety, and 26-63 is severe anxiety. In the present study, the Chinese version of the BAI had a Cronbach's α of 0.95 and a split-half reliability of 0.92. The total scores were multiplied by 1.19, and the resulted integers were taken as the standard scores. | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| Depression of participants with PCOS and non-PCOS as assessed by Beck Depression Inventory-second edition (BDI-II) | The Beck Depression Inventory-second edition (BDI-II) was developed by Beck . It measures the depression levels of teenagers and adults through 21 questions. It consists of questions representative of the symptoms and attitudes of depression, such as feeling sad, losing interest, decreased appetite, and feeling tired. For each item, respondents select the option that best describes how they felt over the previous 2 weeks. Every question has anchors arranged according to severity, and the score ranges from 0 to 3 points. The higher the total score is, the more severe the depression symptoms are. A total score of 0-13 points is in the normal range, 14-19 implies mild depression, 20-28 moderate depression, and 29-63 severe depression. | No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study) |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
| D004194 | Disease |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |